Reduced Expression of miR-22 in Gastric Cancer Is Related to Clinicopathologic Characteristics or Patient Prognosis

Diagnostic Pathology- United Kingdom

doi 10.1186/1746-1596-8-102

Full Text

Abstract

Available in

Date

Authors

Publisher

Springer Science and Business Media LLC

Related search

Reduced miR-29a-3p Expression Is Linked to the Cell Proliferation and Cell Migration in Gastric Cancer

World Journal of Surgical Oncology
SurgeryOncology
2015English

Reduced Expression of PTPRD Correlates With Poor Prognosis in Gastric Adenocarcinoma

PLoS ONE
Multidisciplinary
2014English

Thirty-Year Trends in Clinicopathologic Characteristics and Prognosis After Gastrectomy for Gastric Cancer: A Single Institution in Northern China

Journal of Cancer
Oncology
2020English

Decreased Expression of AZGP1 Is Associated With Poor Prognosis in Primary Gastric Cancer

PLoS ONE
Multidisciplinary
2013English

Reduced Expression of Uroplakin 1A Is Associated With the Poor Prognosis of Gastric Adenocarcinoma Patients

PLoS ONE
Multidisciplinary
2014English

A Genetic Variant Located in miR-146b Promoter Region Is Associated With Prognosis of Gastric Cancer

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2018English

Clinicopathologic and Prognostic Characteristics of Alpha-Fetoprotein–producing Gastric Cancer

Oncotarget
Oncology
2017English

High Expression of eIF3d Is Associated With Poor Prognosis in Patients With Gastric Cancer

Cancer Management and Research
Oncology
2017English

High Hepsin Expression Predicts Poor Prognosis in Gastric Cancer

Scientific Reports
Multidisciplinary
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy